-
461
-
462
-
463
Ventricular assist device implantation in children with a mechanical valve: An ACTION registry analysis
Published 2025-02-01Get full text
Article -
464
-
465
October 7th Mass Casualty Attack in Israel: Injury Profiles of Hospitalized Casualties
Published 2024-09-01Get full text
Article -
466
Leveraging Comprehensive Echo Data to Power Artificial Intelligence Models for Handheld Cardiac Ultrasound
Published 2025-03-01Get full text
Article -
467
-
468
Posttraumatic Stress Disorder Is Associated With Endothelial Dysfunction in Women With HIV
Published 2025-02-01Get full text
Article -
469
Brief Mindfulness-Based Cognitive Therapy in Women With Myocardial Infarction
Published 2025-02-01Get full text
Article -
470
-
471
Prognostic Value of Postpercutaneous Coronary Intervention Murray-Law-Based Quantitative Flow Ratio
Published 2025-01-01Get full text
Article -
472
-
473
Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double‐Blind, Parallel‐Group, R...
Published 2025-01-01“…In this phase III, multicenter, double‐blind, parallel‐group, randomized controlled trial, patients aged 18–70 years with mean sitting systolic blood pressure (msSBP) between 140 and <180 mmHg and mean sitting diastolic blood pressure (msDBP) between 90 and <110 mmHg, following a 4‐week treatment with AML 5 mg, were randomized 1:1 to receive either ALI/AML or AML once daily for 12 weeks. …”
Get full text
Article -
474
Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study
Published 2025-01-01“…Among 87 evaluable patients with mTNBC, 22 patients (25.3%) achieved overall response. …”
Get full text
Article -
475
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Published 2025-01-01“…Vδ1 γδ T cells from mTNBC patients produced more IL17 than those from HDs. …”
Get full text
Article -
476
-
477
Mid-Spine Belt of Beautiful China: future reversal of increasing vegetation greening in response to an evolving environment
Published 2025-12-01“…The Mid-Spine Belt of Beautiful China (MSBBC), a novel geographical designation, encompasses agro-pastoral production and living spaces in China. …”
Get full text
Article -
478
Genome-wide identification of high-affinity nitrate transporter 2 (NRT2) gene family under phytohormones and abiotic stresses in alfalfa (Medicago sativa)
Published 2024-12-01“…In this study, the NRT2s gene family were systematically analyzed in alfalfa. We identified three MsNRT2 genes from the genomic database. They were named MsNRT2.1-2.3 based on their chromosomal location. …”
Get full text
Article -
479
Molecular Mechanisms Underlying Anti-Inflammatory Actions of 6-(Methylsulfinyl)hexyl Isothiocyanate Derived from Wasabi (Wasabia japonica)
Published 2012-01-01“…6-(Methylsulfinyl)hexyl isothiocyanate (6-MSITC) is a major bioactive compound in wasabi (Wasabia japonica), which is a typical Japanese pungent spice. …”
Get full text
Article -
480
Efficacy and Safety of Aprocitentan in the Treatment of Hypertension: A Meta-Analysis of Evidence from Randomized Controlled Trials
Published 2025-01-01“…Results: This meta-analysis included five RCTs, which incorporated 1224 patients, and displayed that aprocitentan can reduce the mean sitting systolic blood pressure (msSBP) [(low dose subgroup: mean difference (MD): –3.85 mmHg; 95% confidence interval (CI): –7.47 to –0.23; p = 0.040; medium dose group: MD: –5.56 mmHg; 95% CI: –10.69 to –0.44; p = 0.030)], mean sitting diastolic blood pressure (msDBP) (low dose subgroup: MD: –3.95 mmHg; 95% CI: –4.06 to –3.85; p < 0.001; medium dose group: MD: –4.75 mmHg; 95% CI: –5.91 to –3.60; p < 0.001), 24-hour ambulatory systolic blood pressure (maSBP) (low dose group: MD: –4.18 mmHg; 95% CI: –4.32 to –4.04; p < 0.001; medium dose group: MD: –5.89 mmHg; 95% CI: –6.03 to –5.75; p < 0.001), and 24-hour ambulatory diastolic blood pressure (maDBP) (low dose group: MD: –4.33 mmHg; 95% CI: –4.42 to –4.24; p < 0.001; medium dose group: MD: –5.82 mmHg; 95% CI: –5.91 to –5.73; p < 0.001). …”
Get full text
Article